Trump layoffs begin to erode FDA drug review system
The Trump administration's mass firings at the U.S. Food and Drug Administration have removed employees critical to reviewing ...
FTC eyes resuming insulin lawsuit against drug middlemen
The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will ...
Eastern Arizona Courier14h
Bill would reinstate peremptory challenges in jury selection
Republican state lawmakers have advanced a bill that would reinstate the ability of trial attorneys on both sides of a case to reject up to four potential jury ...
Medical Device Network17h
AliveDx seeks FDA approval for MosaiQ AiPlex CTDplus assay
AliveDx has submitted a 510(k) premarket notification seeking approval from the FDA for its MosaiQ AiPlex CTDplus microarray.
STAT17h
Pharmalittle: We’re reading about FDA scrambling for workers, Pfizer CEO pay and more
Just hours after thousands of U.S. Food and Drug Administration employees were shown the door, Barclay Butler, the agency’s ...
Medical Device Network on MSN19h
‘Fear and uncertainty’ linger over FDA’s future in wake of Trump admin’s layoffs
During a webinar hosted by NAMSA, experts reflected on what US health agency job cuts could mean for device approvals and ...
Compliance challenges and technology gaps amid US regulatory uncertainty, Finextra survey reveals
The latest survey report by Finextra, which included responses from 200 financial services professionals across the US, ...